Yeiman: We've seen a huge kind of surge of interest from technology companies in health care generally. Do you think after a scandal like this, silicon value will continue investing in health tex so heavily? Yeiman: Be haft be really careful, because kind of the burden of care is much higher when you're dealing with some one's health versus agin ap.
A tech startup said it could start a medical revolution with a little machine and a drop of blood. It was a fraud, but research into smarter, less invasive blood testing is a reality.
Today’s show was produced by Will Reid and Miles Bryan, edited by Matt Collette, engineered by Efim Shapiro, fact-checked by Laura Bullard and hosted by Haleema Shah.
Transcript at vox.com/todayexplained
Support Today, Explained by making a financial contribution to Vox! bit.ly/givepodcasts
Learn more about your ad choices. Visit podcastchoices.com/adchoices